16 results
Antibiotics for Intraabdominal Infection. 
Use your local antimicrobial susceptibility data for selecting the best empiric treatment!
Antibiotics for ... intraabdominal #antibiogram ... #infectiousdiseases ... #management #pharmacology ... #treatment
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Parenteral #IV #Antibiotics ... #Osteomyelitis ... #pharmacology # ... idsa
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... Necrotizing Infections ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
define the type of infection ... #management #infectiousdisease ... #antibiotics ... #coverage #antibiogram ... #pharmacology
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
#Oral #Antibiotics ... #Osteomyelitis ... #management #treatment ... #pharmacology # ... idsa
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Clostridium difficile infection ... Episode #Pharmacology ... IDSA2017 #Adjunct #Antibiotics
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... Diabetic Foot Osteomyelitis ... of nonsurgical treatment ... 48–72 h if on treatment ... Diabetic #Foot #Osteomyelitis
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... candida #mucosal #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology